133 related articles for article (PubMed ID: 8012972)
21. Dimethyl sulfoxide-induced transglutaminase activity in murine-derived Friend erythroleukemia cells.
Hsu KH; Friedman H
J Natl Cancer Inst; 1983 May; 70(5):965-9. PubMed ID: 6133025
[TBL] [Abstract][Full Text] [Related]
22. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
23. Ionic regulation of MEL cell commitment.
Levenson R; Macara I; Cantley L; Housman D
J Cell Biochem; 1983; 21(1):1-8. PubMed ID: 6575972
[TBL] [Abstract][Full Text] [Related]
24. Ureido derivatives of pyridine: a new class of inducers of murine erythroleukemia cell differentiation.
Pappas IS; Niopas I; Tsiftsoglou AS
Anticancer Drug Des; 1992 Apr; 7(2):153-61. PubMed ID: 1575888
[TBL] [Abstract][Full Text] [Related]
25. Esterase inhibitors diminish the modulation of gene expression by butyric acid derivative, pivaloyloxymethyl butyrate (AN-9).
Rabizadeh E; Shaklai M; Eisenbach L; Nudelman A; Rephaeli A
Isr J Med Sci; 1996 Dec; 32(12):1186-91. PubMed ID: 9007151
[TBL] [Abstract][Full Text] [Related]
26. Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells.
Deubzer H; Busche B; Rönndahl G; Eikel D; Michaelis M; Cinatl J; Schulze S; Nau H; Witt O
Leuk Res; 2006 Sep; 30(9):1167-75. PubMed ID: 16510182
[TBL] [Abstract][Full Text] [Related]
27. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.
Drach J; Lopez-Berestein G; McQueen T; Andreeff M; Mehta K
Cancer Res; 1993 May; 53(9):2100-4. PubMed ID: 8481912
[TBL] [Abstract][Full Text] [Related]
28. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
Taimi M; Breitman TR
Biochem Biophys Res Commun; 1997 Mar; 232(2):432-6. PubMed ID: 9125196
[TBL] [Abstract][Full Text] [Related]
29. A new class of inhibitors of lymphocyte mitogenesis: agents that induce erythroid differentiation in Friend leukemia cells.
Novogrodsky A; Rubin AL; Stenzel KH
J Immunol; 1980 Apr; 124(4):1892-7. PubMed ID: 7189200
[TBL] [Abstract][Full Text] [Related]
30. Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells.
Kim HH; Sik Bang S; Seok Choi J; Han H; Kim IH
Cancer Lett; 2005 Jun; 223(2):191-201. PubMed ID: 15896453
[TBL] [Abstract][Full Text] [Related]
31. Synergistic induction of 1,25-dihydroxyvitamin D(3)- and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps.
Kim SH; Kim TS
Planta Med; 2002 Oct; 68(10):886-90. PubMed ID: 12391550
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
33. Demonstration of commitment by K562 human erythroleukemia cells.
Rowley PT; Ohlsson-Wilhelm BM
Prog Clin Biol Res; 1985; 191():217-31. PubMed ID: 3863148
[TBL] [Abstract][Full Text] [Related]
34. Basic principles for utilizing combination differentiation agents.
Waxman S; Scher W; Scher BM
Cancer Detect Prev; 1986; 9(3-4):395-407. PubMed ID: 3527418
[TBL] [Abstract][Full Text] [Related]
35. Alterations in membrane lipid dynamics of leukemic cells undergoing growth arrest and differentiation: dependency on the inducing agent.
Nathan I; Ben-Valid I; Henzel R; Masalha H; Baram SN; Dvilansky A; Parola AH
Exp Cell Res; 1998 Mar; 239(2):442-6. PubMed ID: 9521862
[TBL] [Abstract][Full Text] [Related]
36. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
37. Inducers of erythroid differentiation in K562 human leukemia cells.
Rowley PT; Ohlsson-Wilhelm BM; Farley BA; LaBella S
Exp Hematol; 1981 Jan; 9(1):32-7. PubMed ID: 6940756
[TBL] [Abstract][Full Text] [Related]
38. Effect of 5-azacytidine on the differentiation of human leukemia K-562 cells.
Sasaki R; Miura Y
Int J Cell Cloning; 1986 May; 4(3):192-202. PubMed ID: 2422298
[TBL] [Abstract][Full Text] [Related]
39. Characterization of sublines of HL-60 human leukemia cells resistant to induction of differentiation by butyric acid.
Fischkoff SA; Hoessly MC; Rossi RM
Leukemia; 1990 Apr; 4(4):302-6. PubMed ID: 2164121
[TBL] [Abstract][Full Text] [Related]
40. Releasing effect of thymidine on G1 phase arrest of erythroleukemia cells caused by FUDR and HMBA.
Bin X; DiLiberto M; Rifkind RA; Marks PA
Zhongguo Yao Li Xue Bao; 1984 Jun; 5(2):133-7. PubMed ID: 6235712
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
